John Hardy (geneticist): Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
Line 1: Line 1:
{{Infobox scientist
'''John Anthony Hardy''' [[Fellow of the Royal Society|FRS]] (born 9 November 1954) is a human [[geneticist]] and [[molecular biologist]] whose research interests focus on [[neurological disease]].
| name = John Hardy
| birth_name = John Anthony Hardy
| native_name_lang =
| image = <!--(filename only, i.e. without "File:" prefix)-->
| image_size =
| alt =
| caption =
| birth_date = {{birth date and age |1964|11|09}}
| birth_place =
| death_date = <!--{{death date and age |YYYY|MM|DD |YYYY|MM|DD}} (death date then birth date)-->
| death_place =
| death_cause =
| resting_place =
| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}-->
| other_names =
| residence =
| citizenship =
| nationality =
| fields =
| workplaces = {{Plainlist|
* [[Mayo Clinic]]
* [[University College London]]}}
| patrons =
| education =
| alma_mater = {{Plainlist|
* [[University of Leeds]] (BSc)
* [[Imperial College London]] (PhD)}}
| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )-->
| thesis_url = <!--(or | thesis1_url = and | thesis2_url = )-->
| thesis_year = <!--(or | thesis1_year = and | thesis2_year = )-->
| doctoral_advisor = <!--(or | doctoral_advisors = )-->
| academic_advisors =
| doctoral_students =
| notable_students =
| known_for =
| influences =
| influenced =
| awards = {{Plainlist|
* [[Breakthrough Prize in Life Sciences]]
* [[Fellow of the Royal Society|FRS]] (2009)<ref name=frs/>
* [[FMedSci]]<ref name=fmedsci>{{cite web|url=http://www.acmedsci.ac.uk/fellows/fellows-directory/ordinary-fellows/professor-john-hardy/|title=Professor John Hardy FRS FMedSci}}</ref>}}
| spouse = <!--(or | spouses = )-->
| partner = <!--(or | partners = )-->
| children =
| signature = <!--(filename only)-->
| signature_alt =
| website = {{URL|https://www.ucl.ac.uk/rlweston-inst/people/john}}
| footnotes =
}}'''John Anthony Hardy''' [[Fellow of the Royal Society|FRS]]<ref name=frs/> (born 9 November 1954) is a human [[geneticist]] and [[molecular biologist]] whose research interests focus on [[neurological disease]].<ref name=whoswho>{{Who's Who | surname = HARDY | othernames = Prof. John | id = U254852 | volume = 2015 | edition = online [[Oxford University Press]]}} {{subscription required}}</ref><ref name="HuttonHeutink1998">{{cite journal|last1=Hutton|first1=Mike|last2=Heutink|first2=Peter|last3=Lendon|first3=Corinne L.|last4=Rizzu|first4=Patrizia|last5=Baker|first5=Matt|last6=Froelich|first6=Susanne|last7=Houlden|first7=Henry|last8=Pickering-Brown|first8=Stuart|last9=Chakraverty|first9=Sumi|last10=Isaacs|first10=Adrian|last11=Grover|first11=Andrew|last12=Hackett|first12=Jennifer|last13=Adamson|first13=Jennifer|last14=Lincoln|first14=Sarah|last15=Dickson|first15=Dennis|last16=Davies|first16=Peter|last17=Petersen|first17=Ronald C.|last18=Stevens|first18=Martijn|last19=de Graaff|first19=Esther|last20=Wauters|first20=Erwin|last21=van Baren|first21=Jeltje|last22=Hillebrand|first22=Marcel|last23=Joosse|first23=Marijke|last24=Kwon|first24=Jennifer M.|last25=Nowotny|first25=Petra|last26=Che|first26=Lien Kuei|last27=Norton|first27=Joanne|last28=Morris|first28=John C.|last29=Reed|first29=Lee A.|last30=Trojanowski|first30=John|last31=Basun|first31=Hans|last32=Lannfelt|first32=Lars|last33=Neystat|first33=Michael|last34=Fahn|first34=Stanley|last35=Dark|first35=Francis|last36=Tannenberg|first36=Tony|last37=Dodd|first37=Peter R.|last38=Hayward|first38=Nick|last39=Kwok|first39=John B. J.|last40=Schofield|first40=Peter R.|last41=Andreadis|first41=Athena|last42=Snowden|first42=Julie|last43=Craufurd|first43=David|last44=Neary|first44=David|last45=Owen|first45=Frank|last46=Oostra|first46=Ben A.|last47=Hardy|first47=John|last48=Goate|first48=Alison|last49=van Swieten|first49=John|last50=Mann|first50=David|last51=Lynch|first51=Timothy|journal=Nature|volume=393|issue=6686|year=1998|pages=702–705|issn=00280836|doi=10.1038/31508|pmid=9641683|title=Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17}}</ref><ref name="GoateChartier-Harlin1991">{{cite journal|last1=Goate|first1=Alison|last2=Chartier-Harlin|first2=Marie-Christine|last3=Mullan|first3=Mike|last4=Brown|first4=Jeremy|last5=Crawford|first5=Fiona|last6=Fidani|first6=Liana|last7=Giuffra|first7=Luis|last8=Haynes|first8=Andrew|last9=Irving|first9=Nick|last10=James|first10=Louise|last11=Mant|first11=Rebecca|last12=Newton|first12=Phillippa|last13=Rooke|first13=Karen|last14=Roques|first14=Penelope|last15=Talbot|first15=Chris|last16=Pericak-Vance|first16=Margaret|last17=Roses|first17=Alien|last18=Williamson|first18=Robert|last19=Rossor|first19=Martin|last20=Owen|first20=Mike|last21=Hardy|first21=John|title=Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease|journal=Nature|volume=349|issue=6311|year=1991|pages=704–706|issn=0028-0836|doi=10.1038/349704a0}}</ref><ref name="Hardy2002">{{cite journal|last1=Hardy|first1=J.|title=The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics|journal=Science|volume=297|issue=5580|year=2002|pages=353–356|issn=00368075|doi=10.1126/science.1072994}}</ref>


==Career==
==Education==
Hardy received his B.Sc. (Hons) degree from the University of Leeds, UK (1976)<ref name="Neuroscience NIH">[http://neuroscience.nih.gov/Lab.asp?Org_ID=436/ Neuroscience NIH]</ref> and three years later his Ph.D. from Imperial College, London, UK<ref name="Neuroscience NIH"/> where he studied dopamine and amino acid neuropharmacology. Dr. Hardy performed his postdoctoral training at the MRC Neuropathogenesis Unit in [[Newcastle upon Tyne]], England and then further postdoctoral work at the Swedish Brain Bank in [[Umeå]], Sweden where he started to work on [[Alzheimer's disease]].<ref name="Neuroscience NIH"/>
Hardy received his [[Bachelor of Science]] degree from the [[University of Leeds]] in 1976<ref name="Neuroscience NIH">[http://neuroscience.nih.gov/Lab.asp?Org_ID=436/ Neuroscience NIH] {{dead}}</ref> and three years later his [[PhD]] from [[Imperial College London]].<ref name="Neuroscience NIH"/> where he studied dopamine and amino acid neuropharmacology.


==Career and research==
He became Assistant Professor of Biochemistry at [[St Mary's Hospital, London|St. Mary's Hospital]], [[Imperial College]], London in 1985 and initiated genetic studies of Alzheimer's disease there.<ref name="HIH.gov">[http://www.nia.nih.gov/NewsAndEvents/JohnHardyPhD.htm/ HIH.gov]</ref> He became Associate Professor in 1989 and then took the Pfeiffer Endowed Chair of Alzheimer's Research at the [[University of South Florida]], in [[Tampa]] in 1992. In 1996 he moved to [[Mayo Clinic]] in [[Jacksonville]], [[Florida]], as Consultant and Professor of [[Neuroscience]].
Following his PhD, Hardy did [[postdoctoral research]] at the MRC Neuropathogenesis Unit in [[Newcastle upon Tyne]], England and then further postdoctoral work at the Swedish Brain Bank in [[Umeå]], Sweden where he started to work on [[Alzheimer's disease]].<ref name="Neuroscience NIH"/>

He became Assistant Professor of Biochemistry at [[St Mary's Hospital, London|St. Mary's Hospital]], [[Imperial College]], London in 1985 and initiated genetic studies of Alzheimer's disease there.<ref name="HIH.gov">[http://www.nia.nih.gov/NewsAndEvents/JohnHardyPhD.htm/ HIH.gov]{{dead}}</ref> He became Associate Professor in 1989 and then took the Pfeiffer Endowed Chair of Alzheimer's Research at the [[University of South Florida]], in [[Tampa]] in 1992. In 1996 he moved to [[Mayo Clinic]] in [[Jacksonville]], [[Florida]], as Consultant and Professor of [[Neuroscience]].


He became Chair of Neuroscience in 2000 and moved to [[National Institute of Aging|National Institute of Ageing]], Bethesda, Maryland, as Chief of the Laboratory of Neurogenetics in 2001. In 2007 he took up the Chair of Molecular Biology of Neurological Disease at the [[Reta Lila Weston Institute of Neurological Studies]], [[University College London]].
He became Chair of Neuroscience in 2000 and moved to [[National Institute of Aging|National Institute of Ageing]], Bethesda, Maryland, as Chief of the Laboratory of Neurogenetics in 2001. In 2007 he took up the Chair of Molecular Biology of Neurological Disease at the [[Reta Lila Weston Institute of Neurological Studies]], [[University College London]].


==Honours and Awards==
==Honours and Awards==
Among others (see below) he has won the Breakthrough Prize for dissecting the causes of Alzheimer’s disease, Parkinson's disease and frontotemporal dementia; the MetLife prize for research into Alzheimer's disease, and the [[Potamkin Prize]] for his work in describing the first [[genetic mutation]]s in the amyloid gene in Alzheimer's disease, in 1991. He was elected a [[Fellow of the Royal Society]] in 2009.
Among others (see below) he has won the [[Breakthrough Prize in Life Sciences]] for dissecting the causes of [[Alzheimer’s disease]], [[Parkinson's disease]] and frontotemporal dementia; the MetLife prize for research into Alzheimer's disease, and the [[Potamkin Prize]] for his work in describing the first [[genetic mutation]]s in the amyloid gene in Alzheimer's disease, in 1991. He was elected a [[List of Fellows of the Royal Society elected in 2009|Fellow of the Royal Society (FRS) in 2009]].<ref name=frs/>
{{colbegin||35em}}

2015 - [https://breakthroughprize.org/ Breakthrough Prize 2016]
*2015 - [[Breakthrough Prize in Life Sciences]] <ref>https://breakthroughprize.org/ Breakthrough Prize 2016</ref>
*2015 - Member of the [[European Molecular Biology Organization|European Molecular Biology Organization (EMBO)]]<ref name=embo>{{cite web|url=http://www.embo.org/documents/members/The_EMBO_Pocket_Directory.pd|title=The EMBO Pocket Directory|archiveurl=https://web.archive.org/web/20150316002020/http://www.embo.org/documents/members/The_EMBO_Pocket_Directory.pdf|archivedate=2015-03-16|publisher=European Molecular Biology Organization}}</ref><ref>{{cite web|url=http://www.embo.org/news/press-releases/press-releases-2015/embo-announces-new-members-for-2015|title=EMBO announces new members for 2015|location=Heidelberg|publisher=[[European Molecular Biology Organization]]}}</ref>

*2014 - the [[The Michael J. Fox Foundation]] award for Parkinson research <ref>[https://www.michaeljfox.org/foundation/news-detail.php?leader-in-parkinson-genetics-research-honored-with-2015-robert-pritzker-prize Pritzker, MJ Fox Award for Parkinson Research]</ref>
2015 - Fellow of [http://www.embo.org/news/press-releases/press-releases-2015/embo-announces-new-members-for-2015 EMBO]
*2014 - Thuduchum Medal, Biochemistry Society

*2014 - [[Dan David Prize]]<ref>{{cite web|url=http://www.dandavidprize.org/laureates/2014/175-present-combatting-memory-loss/624-prof-john-a-hardy|title=Dan David Prize: LAUREATES 2014: Combatting Memory Loss, JOHN A. HARDY}}</ref>
2014 - [https://www.michaeljfox.org/foundation/news-detail.php?leader-in-parkinson-genetics-research-honored-with-2015-robert-pritzker-prize Pritzker, MJ Fox Award for Parkinson Research]
*2011 - Elected Fellow of the [[Institute of Biology]]{{fact}}

*2010 - Honorary Doctor of Science, [[Newcastle University]]{{fact}}
2014 - Thuduchum Medal, Biochemistry Society
*[[List of Fellows of the Royal Society elected in 2009|2009 - Elected Fellow of the Royal Society]]<ref name=frs>{{cite web|url=https://royalsociety.org/people/john-hardy-11582/|title=Professor John Hardy FMedSci FRS|publisher=[[Royal Society]]|location=London}}</ref>

* 2008 - Honorary MD, University of Umea, Sweden
2014 - [http://www.dandavidprize.org/laureates/2014/175-present-combatting-memory-loss/624-prof-john-a-hardy Dan David Prize]
* 2008 - Elected to membership of the Academy of Medical Sciences<ref name=fmedsci/>

* 2008 - Anne Marie Oprecht International Prize for Research in Parkinson’s Disease
2011 - Elected Fellow of the Institute of Biology
* 2002 - Kaul Prize for Research into Alzheimer’s disease

* 1995 - MetLife Prize for Research into Alzheimer’s disease
2010 - Honorary Doctor of Science, Newcastle University
* 1995 - Allied Signal Prize for Research into Aging

* 1993 - Potamkin Prize (American Academy of Neurology) for Alzheimer's Research
2009 - Elected Fellow of the Royal Society
* 1992 - IPSEN Prize for Research into Alzheimer's Disease

2008 - Honorary MD, University of Umea, Sweden
* 1991 - Peter Debje Prize, University of Limburg, Belgium, For Alzheimer's Research
{{colend}}

2008 - Elected to membership of the Academy of Medical Sciences

2008 - Anne Marie Oprecht International Prize for Research in Parkinson’s Disease

2002 - Kaul Prize for Research into Alzheimer’s disease

1995 - MetLife Prize for Research into Alzheimer’s disease

1995 - Allied Signal Prize for Research into Aging

1993 - Potamkin Prize (American Academy of Neurology) for Alzheimer's Research

1992 - IPSEN Prize for Research into Alzheimer's Disease

1991 - Peter Debje Prize, University of Limburg, Belgium, For Alzheimer's Research


==References==
==References==
{{reflist|35em}}
<references/>


{{Authority control}}
{{Authority control}}
Line 69: Line 106:
[[Category:University of South Florida faculty]]
[[Category:University of South Florida faculty]]
[[Category:Academics of University College London]]
[[Category:Academics of University College London]]
[[Category:Members of the European Molecular Biology Organization]]





Revision as of 07:29, 27 November 2015

John Hardy
Born
John Anthony Hardy

(1964-11-09) November 9, 1964 (age 59)
Alma mater
Awards
Scientific career
Institutions
Websitewww.ucl.ac.uk/rlweston-inst/people/john

John Anthony Hardy FRS[1] (born 9 November 1954) is a human geneticist and molecular biologist whose research interests focus on neurological disease.[3][4][5][6]

Education

Hardy received his Bachelor of Science degree from the University of Leeds in 1976[7] and three years later his PhD from Imperial College London.[7] where he studied dopamine and amino acid neuropharmacology.

Career and research

Following his PhD, Hardy did postdoctoral research at the MRC Neuropathogenesis Unit in Newcastle upon Tyne, England and then further postdoctoral work at the Swedish Brain Bank in Umeå, Sweden where he started to work on Alzheimer's disease.[7]

He became Assistant Professor of Biochemistry at St. Mary's Hospital, Imperial College, London in 1985 and initiated genetic studies of Alzheimer's disease there.[8] He became Associate Professor in 1989 and then took the Pfeiffer Endowed Chair of Alzheimer's Research at the University of South Florida, in Tampa in 1992. In 1996 he moved to Mayo Clinic in Jacksonville, Florida, as Consultant and Professor of Neuroscience.

He became Chair of Neuroscience in 2000 and moved to National Institute of Ageing, Bethesda, Maryland, as Chief of the Laboratory of Neurogenetics in 2001. In 2007 he took up the Chair of Molecular Biology of Neurological Disease at the Reta Lila Weston Institute of Neurological Studies, University College London.

Honours and Awards

Among others (see below) he has won the Breakthrough Prize in Life Sciences for dissecting the causes of Alzheimer’s disease, Parkinson's disease and frontotemporal dementia; the MetLife prize for research into Alzheimer's disease, and the Potamkin Prize for his work in describing the first genetic mutations in the amyloid gene in Alzheimer's disease, in 1991. He was elected a Fellow of the Royal Society (FRS) in 2009.[1]

References

  1. ^ a b c d "Professor John Hardy FMedSci FRS". London: Royal Society.
  2. ^ a b "Professor John Hardy FRS FMedSci".
  3. ^ HARDY. "HARDY, Prof. John". Who's Who. Vol. 2015 (online Oxford University Press ed.). A & C Black. {{cite encyclopedia}}: Unknown parameter |othernames= ignored (help) (Subscription or UK public library membership required.) (subscription required)
  4. ^ Hutton, Mike; Heutink, Peter; Lendon, Corinne L.; Rizzu, Patrizia; Baker, Matt; Froelich, Susanne; Houlden, Henry; Pickering-Brown, Stuart; Chakraverty, Sumi; Isaacs, Adrian; Grover, Andrew; Hackett, Jennifer; Adamson, Jennifer; Lincoln, Sarah; Dickson, Dennis; Davies, Peter; Petersen, Ronald C.; Stevens, Martijn; de Graaff, Esther; Wauters, Erwin; van Baren, Jeltje; Hillebrand, Marcel; Joosse, Marijke; Kwon, Jennifer M.; Nowotny, Petra; Che, Lien Kuei; Norton, Joanne; Morris, John C.; Reed, Lee A.; Trojanowski, John; Basun, Hans; Lannfelt, Lars; Neystat, Michael; Fahn, Stanley; Dark, Francis; Tannenberg, Tony; Dodd, Peter R.; Hayward, Nick; Kwok, John B. J.; Schofield, Peter R.; Andreadis, Athena; Snowden, Julie; Craufurd, David; Neary, David; Owen, Frank; Oostra, Ben A.; Hardy, John; Goate, Alison; van Swieten, John; Mann, David; Lynch, Timothy (1998). "Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17". Nature. 393 (6686): 702–705. doi:10.1038/31508. ISSN 0028-0836. PMID 9641683.
  5. ^ Goate, Alison; Chartier-Harlin, Marie-Christine; Mullan, Mike; Brown, Jeremy; Crawford, Fiona; Fidani, Liana; Giuffra, Luis; Haynes, Andrew; Irving, Nick; James, Louise; Mant, Rebecca; Newton, Phillippa; Rooke, Karen; Roques, Penelope; Talbot, Chris; Pericak-Vance, Margaret; Roses, Alien; Williamson, Robert; Rossor, Martin; Owen, Mike; Hardy, John (1991). "Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease". Nature. 349 (6311): 704–706. doi:10.1038/349704a0. ISSN 0028-0836.
  6. ^ Hardy, J. (2002). "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics". Science. 297 (5580): 353–356. doi:10.1126/science.1072994. ISSN 0036-8075.
  7. ^ a b c Neuroscience NIH [dead link]
  8. ^ HIH.gov[dead link]
  9. ^ https://breakthroughprize.org/ Breakthrough Prize 2016
  10. ^ "The EMBO Pocket Directory" (PDF). European Molecular Biology Organization. Archived from the original on 2015-03-16.
  11. ^ "EMBO announces new members for 2015". Heidelberg: European Molecular Biology Organization.
  12. ^ Pritzker, MJ Fox Award for Parkinson Research
  13. ^ "Dan David Prize: LAUREATES 2014: Combatting Memory Loss, JOHN A. HARDY".

Template:Persondata